Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
...ODLANDS, Texas, Aug. 4 /PRNewswire-FirstCall/ -- lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ), a bioph...y completed Phase 1 testing in normal volunteers. lexicon
also successfully completed a drug-drug interactio...e-1-phosphate (S1P) lyase, an enzyme identified by lexicon
scientists as a promising new target on a pathway ...
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
...DLANDS, Texas, July 28 /PRNewswire-FirstCall/ -- lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ), a bioph...ar future."
advanced its LX1032 drug candidate, which has ...nt with currently available therapy. In addition, lexicon
presented Phase 1 data for LX1032 at the Digestive...
Zix Corporation Selected by Houston Healthcare for Email Encryption Service
...nforce Houston Healthcare's email encryption policies to ensure the secure handling of confidential information. The service includes a pre-configured lexicon
that automatically detects and encrypts protected health information ("PHI"). ZixCorp will also provide branding and encrypted messaging functionality...
Aerobics Celebrates 40th Anniversary
...t also changed the world.
March marks the 40th anniversary of the 1968 release of Aerobics, a
revolutionary book that introduced a new word into the lexicon
a worldwide fitness movement. The invention of a young U.S. Air Force
physician named Kenneth H. Cooper, Aerobics was born in a quest to ...
Princeton scientists break cholera's lines of communication
...t pathway into the clinic."
The field is still far from possessing a complete dictionary of the bacterial chemical lexicon, Bassler said, and this lexicon
must be better understood before clinical applications can be developed. But the findings are encouraging.
"We have to show that CAI-1 can cure ch...
Pharmacopeia Announces Senior Additions to Management Team
...ly, he will serve as a
key participant in the leadership of all alliances. Dr. Kimball most recently served as Vice President, Medicinal Chemistry
Pharmaceuticals, where he successfully directed that company's
chemistry effort to discover drug candidates in multiple therapeutic areas,
several of ...
Ultrasound Better Than Biopsy for Breast Examination
...-up of masses that were classified as probably benign at initial ultrasound.
Our study shows that following a lesion classified in the BI-RADS lexicon
as category 3 is a safe alternative to immediate biopsy, Dr. Graf said. But it is essential that lesions strictly meet these criteria.
This World Heart Day, Be Proactive, Get the Facts
...y disease is very good."
Mr. V. Raja, President & CEO, GE Healthcare South Asia said, "Perhaps the most beautiful word in the entire medical lexicon
is "early." After all, "early" is optimal for diagnosis and treatment. And thanks to new advanced technologies like LightSpeed Volume CT available to...
Lexicon in Medical Technology
Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
...DLANDS, Texas, July 21 /PRNewswire-FirstCall/ -- lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ), a bioph...sign. LX1032 is the first drug candidate for which lexicon
has obtained orphan drug status.
"Gaining...integrated global development strategy."
recently initiated a Phase 2 clinical trial of LX1...
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
...LANDS, Texas, April 28 /PRNewswire-FirstCall/ -- lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ), a bioph...eline."
completed a drug-drug interaction study of LX293...rug-drug interactions were observed. In addition, lexicon
will present Phase 1 data for LX2931 at the Europe...
Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
...ODLANDS, Texas, March 5 /PRNewswire-FirstCall/ -- lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopha... Lexicon's mouse models and preclinical research. lexicon
is planning to initiate a Phase 2 clinical trial o...l Partners, L.P. and its co-investors.
Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
...d showed good systemic exposure.
is a biopharmaceutical company focused on the disc...ment of breakthrough treatments for human disease. lexicon
has clinical programs underway for such ...development and commercialization of its programs, lexicon
is working both
independently and through collabor...
Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
...ety, tolerability, and pharmacokinetics of
expects to initiate clinical trials with LX2931 fo...ple in
the United States. LX2931 was developed at lexicon
as an inhibitor of a key enzyme in the
sphingolipi... reduction in peripheral lymphocyte counts. About lexicon
Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
...OODLANDS, Texas, Oct. 15 /PRNewswire-FirstCall/
Pharmaceuticals, Inc. (Nasdaq: LXRX ) presented d...apital Partners, L.P. and its co-investors. About lexicon lexicon
is a biopharmaceutical company focused on the disc...
Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
...general oral session and the paper
number is 235. lexicon
will also present a separate poster titled, "Open ...ion which begins at 7:00 p.m. Eastern Time. About lexicon lexicon
is a biopharmaceutical company focused on the disc...
Lexicon-Genentech Collaboration Yields Potential Therapeutic
...t discoveries were made in a collaboration
and Genentech that was initiated in December 2002
and commercialization of new biologic drugs. lexicon
antibodies for one of these targets,... to decrease plasma triglycerides and
has the option to choose six targets from the
Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune
...adelphia, PA. Together with David L.
Wiest, Ph.D., lexicon
researchers have discovered a novel and
surprising...he journal Immunity.
Dr. Wiest and scientists at lexicon
that deletion of the ub...its potential as a biomarker for disease."
Lexicon Develops Antibodies That Lower Triglycerides and
Cholesterol as Potential New Therapy for Heart Disease
...Proceedings of the National Academy
scientists first identified ANGPTL4 as a potential...he company's proprietary
gene knockout technology. lexicon
scientists create animal models
that have alterati...ive vice president and chief scientific officer
and an author on the paper. "The research our team...
Lexicon in Medical Dictionary
..... Searching for Toys in Whitehead , AL? Find Toys and more in Whitehead , AL at JustClickLocal.com Consequently, Whitehead invented a new lexicon
of terms, seeking to escape ... Three of his books convey the bulk of Whitehead's metaphysical contribution. ... Along with Dr. John Snow, studi...
Lexicon in Biological News
Decoding the dictionary: Study suggests lexicon evolved to fit in the brain
Troy, N.Y. The latest edition of the Oxford English Dictionary boasts 22,000 pages of definitions. While that may seem far from succinct, new research suggests the reference manual is meticulously organized to be as concise as possible a format that mirrors the way our brains make sense of and c...
The emerging scientific discipline of aeroecology
...biomechanics and astrobiology with more recent developments of nanotechnology and bioinformatics all disciplines that are now well established in the lexicon
of modern science and technology.
Aeroecology is one such emerging discipline, noted Thomas H. Kunz, Boston University Professor of Biology and Di...
Lexicon in Biological Technology
Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
Collaboration to Apply Chemetics(R) Technology to Lexicon
COPENHAGEN, June 10 /PRNewswire/ -- Nuevolution A/S today announced a
strategic alliance with Lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ) aimed
at the discovery of novel small molecule lead compounds for highly
Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
...DLANDS, Texas, July 22 /PRNewswire-FirstCall/ -- lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ) will rel... July 28, 2009 before the financial markets open. lexicon
management will hold a conference call to discuss ...he website through August 4, 2009.
Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
...ODLANDS, Texas, July 7 /PRNewswire-FirstCall/ -- lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ), a bioph...d by these patients.
In addition to LX1032, lexicon
has three other drug candidates progressing throug...t LX1032
LX1032 was discovered and developed at lexicon
to reduce serotonin production by inhibiting trypt...
2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession
..., September 16.
Additional speakers include BioMarin Pharmaceuticals, Array BioPharma, Reata Pharmaceuticals, Proteolix, Novalar Pharmaceuticals, lexicon
Pharmaceuticals, Orexigen Therapeutics, Targacept, Helsinn Therapeutics, OSI Prosidion, NovaDel Pharma, Anacor Pharmaceuticals, Ceragenix, Millennium ...
Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
...ODLANDS, Texas, June 2 /PRNewswire-FirstCall/ -- lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ) announce...iversity .
"Ajay will be a great asset to the lexicon
management team with his impressive background in ... our commercialization opportunities."
Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
...OODLANDS, Texas, May 27 /PRNewswire-FirstCall/ -- lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ), a bioph...), please visit www.lexpharma.com .
is a biopharmaceutical company focused on discover...
Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
...ODLANDS, Texas, April 21 /PRNewswire-FirstCall/ -- lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ) will relea...April 28, 2009 before the financial markets open. lexicon
management will hold a conference call to discuss ...le on the website through May 5, 2009.
Lexicon Pharmaceuticals 2008 Annual Report to Stockholders Available Online
...DLANDS, Texas, March 13 /PRNewswire-FirstCall/ -- lexicon
Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopha...able its 2008 annual report to stockholders on the lexicon
Pharmaceuticals corporate website at www.lexpharm...m . Hard copies are available, free of charge, to lexicon
stockholders by contacting Lexicon's Investor Rela...
Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research
...cs to contribute to the
health of individuals."
Dr. Landes previously has held executive positions with major
biopharmaceutical companies, including lexicon
Inc. and Genzyme Corp, where he led antibody drug discovery, antibody
development and functional genomics. He has authored m...
Chemistry Outsourcing Conference Unveils 90-Speaker Conference Program to Take Place September 8-9 in New Jersey
...esident Wilmington PharmaTech
Tricia Scialla Director, Material Operations Chemical Development
Winston Wu, Ph.D. Director, Process Chemistry lexicon
Pharmaceuticals Contact Mark Alexay for more information at
email@example.com, 201.452.4023, or visit http://www.chemoutsourcing.com
Lexicon in Biological Definition
...ntil the twentieth century;
the final e came into use to indicate the vowel is a "long o" instead of a "short o".
Since the term entered the popular lexicon
in a more general context,
the spelling clone has been used exclusively.
In biology , cloning is used in two contexts: cloning a gene , or cloni...
Lexicon in Biological Dictionary
...D collects and integrates the gene expression information in MGI. ... Gene Expression Notebook (GEN) Mouse Phenome Database (MPD) Deltagen and lexicon
Knockout Mice ... long oligonucleotide arrays for gene expression analysis including tiling expression , mutiplex expression for a broad r...